Yatharth HOSP & TRA C S L
Yatharth Hosp & Tra C S L (YATHARTH): company summary
The company's business is growing, with annual revenue rising 40.4% and net profit increasing 30.0% year-over-year.
Yatharth Hosp & Tra C S L (YATHARTH) is a small-cap Healthcare company valued at ₹9,559 crore operating in Hospital on the NSE and BSE.
- Recent price move
- Yatharth Hosp & Tra C S L last traded at ₹992.8, modestly up 0.13% on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarterly results, showing revenue of ₹393 crore and net profit of ₹45 crore. The promoter pledged 9.59% of their holding, and foreign institutional holding increased by 0.37 percentage points while domestic institutional holding fell by 1.16 percentage points.
- Financial performance
- The company's business is growing, with annual revenue rising 40.4% and net profit increasing 30.0% year-over-year. The latest quarter saw revenue jump 52.2% compared to the same quarter a year earlier, while net profit grew 8.1%, though the net profit margin narrowed by 1.1 percentage points to 14.1%.
- Valuation multiples
- The stock trades at 54.5 times earnings, a premium to the Healthcare median of 32.0, 5.29 times book value. It yields 0.1%.
- Things to watch
- The company's net profit margin has narrowed by 1.1 percentage points, and it has not paid dividends despite reporting profits. The stock is 12.7% below its 52-week high, and promoter shares pledged account for 9.59% of their holding.
- Where it stands
- The company has shown strong revenue and profit growth over the past five years, with recent quarterly results reflecting continued expansion. The stock is currently 12.7% below its 52-week high, and the promoter has pledged a significant portion of their holding.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.3) and risk (7.5), but held back by valuation (0.0). Growth looks strong at 9.3, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profit compounding 53% a year
- Revenue compounding 41% a year
- Low leverage — D/E 0.14
- Valuation is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Hospital
Explore YATHARTH HOSP & TRA C S L’s valuation
Free deep-dive tools · no sign-up
YATHARTH HOSP & TRA C S L peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare YATHARTH HOSP & TRA C S L with peers
Related tools & concepts
Value YATHARTH HOSP & TRA C S L with the ratios and calculators DocStoX uses in its analysis.

